In the treatment of kidney cancer 'breakthrough'

Increased kidney cancer treatment is a very difficult time. Especially when conventional medicines fail, then it becomes more difficult to treat: Dr. Alan Messengers                            Experts said the new drugs for kidney cancer increased the cure will be changed.

Both drugs increased the survival rate of patients in several experiments.

This research was published in the New England Journal of Medicine.

A drug on the body's immune system could 'break' is removed, he becomes more active, the stop signal is spread within the tumor.

 

The "Cancer Research UK" The progress against cancer to have access to new weapons.

Kidney cancer is the most common cancer in the UK is eight, and if you catch it late in the patient's life is very short.

If the cancer spreads to other parts of the body, then five years after the diagnosis of the patient remains alive.

First experience 'Check Mate 025, called the drug affects the immune system nyulumyb used. The drug is characterized by the body's immune system to the tumor 'off' then give it back 'online' adds.

This type of medicine in the skin and lung cancer have been proven effective.

821 patients were included in the experiment. In the treatment of patients increased by 19.6 months, while patients taking newlumab rose 25 month.

Marsdyn Royal Hospital, James Larkin told the BBC: "The treatment of cancer, and particularly in the treatment of kidney cancer is a major breakthrough."

"Matty and the other 658 patients experience treatment called kybuzynty case was tried. The survival rate was nearly doubled, ie increased from 7.4 months to 3.8 months.

Commenting on the study, Dr. Alan Messengers of Cancer Research UK, said: "The treatment of kidney cancer increased for a long time is very difficult. In these experiments testing drugs for kidney cancer better than traditional medicine ayurulyms.